source
- Lexeo Therapeutics acquires Mantle Therapeutics for $8.3M to expand Friedreich ataxia pipelineLexeo Therapeutics announced it will acquire Mantle Therapeutics for an upfront payment of $8.3 million, aiming to broaden its Friedreich ataxia pipeline. The transaction could rise to $21.3 milli…
- Novo CEO acknowledges need to rebuild investor confidence after muted capital markets dayNovo held a capital markets day on Monday in London, where the company outlined its strategy. Investors said the presentation left them underwhelmed. CEO Mike Doustdar acknowledged the reaction, s…